{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "esgPopulated": false, "market": "se_market", "longName": "Orexo AB (publ)", "marketState": "REGULAR", "regularMarketPrice": 10.6, "messageBoardId": "finmb_6021724", "exchange": "STO", "shortName": "Orexo AB", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Stockholm", "regularMarketChangePercent": 0.0, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.2800007, "fiftyTwoWeekLowChangePercent": 0.02713185, "fiftyTwoWeekRange": "10.32 - 34.3", "fiftyTwoWeekHighChange": -23.699999, "fiftyTwoWeekHighChangePercent": -0.6909621, "fiftyTwoWeekLow": 10.32, "fiftyTwoWeekHigh": 34.3, "earningsTimestamp": 1689660000, "earningsTimestampStart": 1689660000, "earningsTimestampEnd": 1689660000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -6.4, "epsForward": -3.47, "epsCurrentYear": -2.34, "firstTradeDateMilliseconds": 1131523200000, "priceHint": 2, "regularMarketChange": 0.0, "regularMarketTime": 1684142528, "regularMarketDayHigh": 10.6, "regularMarketDayRange": "10.5 - 10.6", "regularMarketDayLow": 10.5, "regularMarketVolume": 6388, "regularMarketPreviousClose": 10.6, "bid": 10.6, "ask": 10.72, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 10.5, "averageDailyVolume3Month": 36751, "averageDailyVolume10Day": 90454, "priceEpsCurrentYear": -4.529915, "sharesOutstanding": 34367600, "bookValue": 3.756, "fiftyDayAverage": 14.24, "fiftyDayAverageChange": -3.6399994, "fiftyDayAverageChangePercent": -0.25561795, "twoHundredDayAverage": 18.8726, "twoHundredDayAverageChange": -8.2726, "twoHundredDayAverageChangePercent": -0.43833917, "marketCap": 370482720, "forwardPE": -3.0547552, "priceToBook": 2.8221512, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "symbol": "ORX.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Rapsgatan 7E", "city": "Uppsala", "country": "Sweden", "phone": "46 1 87 80 88 00", "fax": "46 1 87 80 88 88", "website": "https://www.orexo.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is also developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.", "fullTimeEmployees": 122, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nikolaj  Sorensen", "age": 50, "title": "Pres & CEO", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 5775000, "fmt": "5.78M", "longFmt": "5,775,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fredrik  Jarrsten", "age": 55, "title": "Exec. VP & CFO", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cecilia  Coupland", "age": 46, "title": "Sr. VP & Head of Operations", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Lena  Wange", "title": "Investor Relations & Communications Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Ronn", "age": 46, "title": "Sr. VP and Head of R&D", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Edward  Kim M.B.A., M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert A. Deluca", "age": 61, "title": "Pres of Orexo US Inc", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jesper  Lind", "age": 62, "title": "Advisor", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 1, "compensationRisk": 10, "shareHolderRightsRisk": 1, "overallRisk": 5, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}